ArticleArthroscopy, sports medicine, and rehabilitation2025
No Difference in 10- to 14-Year Outcomes After Modified Transtibial Versus Anteromedial Portal Techniques in Anterior Cruciate Ligament Reconstruction.
Article in Arthroscopy, sports medicine, and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ACL reconstruction in football players: A nationwide Swedish registry study of anteromedial versus transtibial femoral tunnel techniques.Journal of experimental orthopaedics · 2026Article
- Anatomic Anterior Cruciate Ligament Reconstruction Integrating the Outside-In and Transtibial Techniques.Arthroscopy techniques · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the long-term clinical and radiological outcomes of modified transtibial and anteromedial portal techniques in single-bundle anterior cruciate ligament (ACL) reconstruction to provide more comprehensive guidance for treatment. Methods: This study included patients who underwent arthroscopic single-bundle ACL reconstruction with adequate follow-up between January 2010 and December 2014. Patients were grouped according to the surgical techniques used: those who underwent the modified transtibial technique (group 1) and those who underwent the anteromedial portal technique (group 2). Clinical assessments included the 2000 International Knee Documentation Committee subjective knee score, Lysholm knee score, Tegner activity scale, Hospital for Special Surgery Knee score, Lachman test, and pivot-shift test. Radiological evaluations assessed the femoral tunnel's location and length, as well as the inclination angles in the coronal, sagittal, and axial planes through computed tomography scans, while the graft bending angle and ligament maturity were evaluated via magnetic resonance imaging. Results: A total of 73 patients were included: 36 in group 1 and 37 in group 2. No clinically significant differences were observed between the 2 techniques in the International Knee Documentation Committee score (mean difference [MD], 2.7; 95% confidence interval [CI], -1.5 to 6.9; minimal clinically important difference [MCID], 13.8), Lysholm score (MD, -0.1; 95% CI, -5.0 to 4.8; MCID, 8.9), Tegner score (MD, 0.6; 95% CI, -0.3 to 1.5; MCID, 1), and Hospital for Special Surgery Knee score (MD, 3.0; 95% CI, 0.3 to 5.7; MCID, 5.4). However, significant differences were noted in the mean distances from the femoral tunnel center to the posterior condylar surface (36.77% ± 4.60% in group 1 vs 32.14% ± 5.21% in group 2; Conclusions: The modified transtibial and anteromedial portal techniques for ACL reconstruction achieved comparable clinical outcomes. Despite some differences in femoral tunnel placement, there are no significant differences in long-term clinical results. Level of Evidence: III, Retrospective cohort study.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.